Roffman Miller Associates’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-16
Closed -$3.5K 141
2023
Q2
$3.5K Buy
+16
New +$3.57K ﹤0.01% 131
2020
Q1
Sell
-16
Closed -$2K 85
2019
Q4
$2K Buy
+16
New +$2.31K ﹤0.01% 88
2017
Q1
Sell
-62,102
Closed -$3.85M 64
2016
Q4
$3.85M Buy
62,102
+12
+0% +$735 0.58% 45
2016
Q3
$4.02M Sell
62,090
-324
-0.5% -$21.6K 0.65% 44
2016
Q2
$3.95M Buy
62,414
+603
+1% +$35.5K 0.65% 45
2016
Q1
$3.57M Buy
61,811
+3,205
+5% +$181K 0.61% 46
2015
Q4
$3.15M Sell
58,606
-1,096
-2% -$61.8K 0.58% 47
2015
Q3
$3.04M Sell
59,702
-59
-0.1% -$3.18K 0.6% 48
2015
Q2
$3.37M Sell
59,761
-1,117
-2% -$70.5K 0.64% 47
2015
Q1
$4.37M Sell
60,878
-1,287
-2% -$83.6K 0.84% 45
2014
Q4
$3.48M Sell
62,165
-1,796
-3% -$93.8K 0.68% 45
2014
Q3
$3.15M Buy
63,961
+566
+0.9% +$28.8K 0.65% 46
2014
Q2
$3.21M Buy
63,395
+3,632
+6% +$180K 0.68% 47
2014
Q1
$2.67M Buy
59,763
+2,762
+5% +$124K 0.59% 50
2013
Q4
$2.68M Buy
57,001
+5,066
+10% +$256K 0.62% 49
2013
Q3
$2.74M Buy
51,935
+2,547
+5% +$124K 0.69% 51
2013
Q2
$2.23M Buy
+49,388
New +$2.34M 0.59% 53

Other funds holding RMD

Roffman Miller Associates's RMD Position: Q3 2023 in Review

Roffman Miller Associates sold out of ResMed (RMD) in Q3 2023, closing a stake of 16 shares — an estimated $3.5K sold.

Roffman Miller Associates first reported a position in RMD in Q2 2013 and held it in 17 quarters. The position peaked at $4.37M in Q1 2015. 657 funds tracked by Wall St. Rank hold RMD as of Q3 2023.

  • Roffman Miller Associates reported no remaining ResMed position as of Q3 2023 after selling out during the quarter.
  • Roffman Miller Associates sold 16 ResMed shares in Q3 2023, an estimated $3.5K.
  • Roffman Miller Associates first reported a position in ResMed in Q2 2013 and held it in 17 quarters.
  • Roffman Miller Associates's ResMed position peaked at $4.37M in Q1 2015.
  • 657 funds tracked by Wall St. Rank held ResMed as of Q3 2023.

Based on Roffman Miller Associates's 13F filing for Q3 2023, filed 9 Nov 2023.